Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-011412
Filing Date
2025-04-28
Accepted
2025-04-28 17:01:19
Documents
2
Period of Report
2025-04-18

Document Format Files

Seq Description Document Type Size
1 form3-04282025_090416.html 3  
1 form3-04282025_090416.xml 3 1662
2 ex24-04282025_090418.htm EX-24 5163
  Complete submission text file 0001415889-25-011412.txt   8331
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 151 W 42 ST 14TH FLOOR NEW YORK NY 10036
Business Address
Susman Robert Graham (Reporting) CIK: 0002065992 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38906 | Film No.: 25881379